{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007716","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2023-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.094209+00:00","generated_at":"2026-06-18T03:26:00.441098+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CRISPR Therapeutics appoints Raju Prasad as CFO, replaces Brendan Smith","bullets":["Raju Prasad, Ph.D., appointed CFO effective March 14, 2023; previously Partner at William Blair.","Annual salary $465,000, target bonus 45%, option grant for 100,000 shares, RSU grant for 40,000 shares.","Brendan Smith resigned as CFO effective March 13, 2023; no disagreement on financial reporting.","Smith remains employee through March 31, 2023, with continued equity vesting.","Prasad receives $100,000 one-time payment, forfeitable if terminated for cause before March 14, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007716","json":"https://secwatch.observer/filing/0000950170-23-007716.json","markdown":"https://secwatch.observer/filing/0000950170-23-007716.md","text":"https://secwatch.observer/filing/0000950170-23-007716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/0000950170-23-007716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/crsp-20230309.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T03:26:00.441098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc8084e7b8","claim":"Raju Prasad was appointed as Chief Financial Officer at CRISPR Therapeutics AG.","evidence_excerpt":"On March 13, 2023, CRISPR Therapeutics AG (the “Company”) announced the hiring and appointment of Raju Prasad, Ph.D. as its Chief Financial Officer, effective March 14, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/0000950170-23-007716-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}